CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Inventiv Group Holdings Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Inventiv Group Holdings Inc
1 Van De Graaff Drive
Phone: (617) 227-1050p:617 227-1050 Burlington, MA  01803-5188  United States Fax: (302) 636-5454f:302 636-5454
On 8/2/2016, inVentiv Group Holdings Inc filed a Registration Withdrawal Request of its Form S-1 File Number 333-210618 with the SEC.The Company is making this application for withdrawal because the Company has entered into an agreement with Advent International pursuant to which Advent has agreed to make a significant investment in the Company.
This is a Subsidiary, click here for the Parent Company
Business Summary
inVentiv Group Holdings, Inc. is a provider of outsourced clinical development and commercialization services to biopharmaceutical companies. The Company delivers a suite of services to enhance its clients' ability to develop, launch and market their products. The Company operates through two segments: Clinical and Commercial. The Clinical business is a global contract research organization (CRO) that is therapeutically focused, and provides a range of capabilities, including Phase I (early stage) and Phase II-IV clinical development, delivered on a project (full service), functional (strategic resourcing) or hybrid basis. Its Commercial business is a contract commercial organization (CCO), a provider of a suite of complementary commercialization services, including selling solutions, communications, consulting and medication adherence. It offers services on both a standalone basis and as integrated solutions to support clinical development and commercialization.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
----Yes--

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
--YesYes--Yes

Industries
SIC Code Description
8742 Management consulting services
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman and CEO Michael A.Bell
Chairman of the Board, Chief Executive Officer Michael A.Bell 58 9/1/2014 1/1/2014
Chief Financial Officer Jonathan E.Bicknell
18 additional Officers and Directors records available in full report.

Business Names
Business Name
Addison Whitney LLC
Adheris, LLC
Allidura Communications LLC
115 additional Business Names available in full report.

General Information
Outstanding Shares: 5,402,676 (As of 6/28/2016)
Federal Tax Id: 010973593
Fax Number: (302) 636-5454


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, April 10, 2024